RxSight, Inc. RXST
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 23.84% | -73.56% | 6.76% | 16.71% | -43.91% |
| Total Depreciation and Amortization | 19.78% | -2.00% | -0.35% | 10.05% | -1.15% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 14.37% | -6.82% | 9.47% | -21.15% | 59.95% |
| Change in Net Operating Assets | -174.85% | -441.10% | -66.53% | 272.26% | 83.68% |
| Cash from Operations | 12.42% | -875.90% | 5.98% | 72.87% | 50.45% |
| Capital Expenditure | -157.71% | 33.25% | -95.70% | 62.20% | -167.30% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -31.22% | 213.33% | -0.64% | -152.03% | -24.46% |
| Cash from Investing | -47.42% | 192.03% | -6.77% | -161.45% | -29.74% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 0.00% | -177.78% | 147.37% | -533.33% | 76.92% |
| Issuance of Common Stock | 364.58% | -86.36% | 706.11% | -93.67% | 197.13% |
| Repurchase of Common Stock | 100.00% | -23,550.00% | 99.69% | -- | 100.00% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 297.02% | -131.61% | 300.57% | -125.67% | 380.95% |
| Foreign Exchange rate Adjustments | 0.00% | 120.00% | -650.00% | -114.29% | 133.33% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -77.65% | 75.46% | 9.70% | -186.79% | 9.39% |